血浆NT-proBNP,LA,CRP联合检测对AMI预后的评估价值

目的:探讨脑钠素(NT-proBNP)、乳酸(LA)、C反应蛋白(CRP)联合检测对急性心肌梗死预后的评估价值。方法:分析2008年至2010年的92例急性心肌梗死(AMI)患者发生心脏不良事件的情况,比较发生心脏不良事件(MACE)组和未发生心脏不良事件组的NT-proBNP,LA和CRP。结果:发生MACE组的NT-proBNP,LA和CRP均高于未发生MACE组,差异均具有统计学意义(P<0.05)。结论:NT-proBNP,LA,CRP联合检测对急性心肌梗死后发生MACE有较好的预警作用。

To Reveal Prognostic Value of Combined Detection of NT-proBNP,LA and CRP in Plasma with AMI

Objective: To reveal prognostic value of combined detection of NT-proBNP,LA and CRP in the plasma with acute myocardial infarction(AMI). Method: Analysis of cardiac adverse events with 92 cases of AMI in the 2008-2010 year,comparison the NT-proBNP, LA and CRP between the groups of occurred adverse cardiac events and did not occur adverse cardiac events. Result: The level of NT-proBNP,LA,and CRP in the adverse cardiac events occurred group were all higher than those without adverse cardiac events group,the differences were statistically significant (P<0.05). Conclusion: Combined detection of NT-proBNP,LA and CRP in patients with AMI maybe a good early-warning function of occurred adverse cardiac events.